trimethyloxamine has been researched along with Metabolic Syndrome in 12 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Choline was not significantly altered in MetS." | 1.48 | Changes to trimethylamine-N-oxide and its precursors in nascent metabolic syndrome. ( Huet, B; Jialal, I; Lent-Schochet, D; McLaughlin, M; Silva, R, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ringel, C | 1 |
| Dittrich, J | 1 |
| Gaudl, A | 1 |
| Schellong, P | 1 |
| Beuchel, CF | 1 |
| Baber, R | 1 |
| Beutner, F | 1 |
| Teren, A | 1 |
| Engel, C | 1 |
| Wirkner, K | 1 |
| Thiele, H | 1 |
| Büttner, P | 1 |
| Löffler, M | 1 |
| Scholz, M | 1 |
| Thiery, J | 1 |
| Ceglarek, U | 1 |
| Kuo, CH | 1 |
| Liu, CH | 1 |
| Wang, JH | 1 |
| Hsu, BG | 1 |
| Gao, X | 1 |
| Sun, C | 1 |
| Zhang, Y | 2 |
| Hu, S | 1 |
| Li, D | 1 |
| Bestavashvili, A | 1 |
| Glazachev, O | 1 |
| Ibragimova, S | 1 |
| Suvorov, A | 1 |
| Bestavasvili, A | 1 |
| Ibraimov, S | 1 |
| Zhang, X | 1 |
| Pavlov, C | 1 |
| Syrkina, E | 1 |
| Syrkin, A | 1 |
| Kopylov, P | 1 |
| Chen, S | 1 |
| Henderson, A | 1 |
| Petriello, MC | 1 |
| Romano, KA | 1 |
| Gearing, M | 1 |
| Miao, J | 1 |
| Schell, M | 1 |
| Sandoval-Espinola, WJ | 1 |
| Tao, J | 1 |
| Sha, B | 1 |
| Graham, M | 1 |
| Crooke, R | 1 |
| Kleinridders, A | 1 |
| Balskus, EP | 1 |
| Rey, FE | 1 |
| Morris, AJ | 1 |
| Biddinger, SB | 1 |
| Org, E | 1 |
| Blum, Y | 1 |
| Kasela, S | 1 |
| Mehrabian, M | 1 |
| Kuusisto, J | 1 |
| Kangas, AJ | 1 |
| Soininen, P | 1 |
| Wang, Z | 1 |
| Ala-Korpela, M | 1 |
| Hazen, SL | 1 |
| Laakso, M | 1 |
| Lusis, AJ | 1 |
| Lent-Schochet, D | 1 |
| Silva, R | 1 |
| McLaughlin, M | 1 |
| Huet, B | 1 |
| Jialal, I | 1 |
| Canyelles, M | 1 |
| Tondo, M | 1 |
| Cedó, L | 1 |
| Farràs, M | 1 |
| Escolà-Gil, JC | 1 |
| Blanco-Vaca, F | 1 |
| Barrea, L | 1 |
| Annunziata, G | 1 |
| Muscogiuri, G | 1 |
| Di Somma, C | 1 |
| Laudisio, D | 1 |
| Maisto, M | 1 |
| de Alteriis, G | 1 |
| Tenore, GC | 1 |
| Colao, A | 1 |
| Savastano, S | 1 |
| Joris, BR | 1 |
| Gloor, GB | 1 |
| Tripolt, NJ | 1 |
| Leber, B | 1 |
| Triebl, A | 1 |
| Köfeler, H | 1 |
| Stadlbauer, V | 1 |
| Sourij, H | 1 |
| Mueller, DM | 1 |
| Allenspach, M | 1 |
| Othman, A | 1 |
| Saely, CH | 1 |
| Muendlein, A | 1 |
| Vonbank, A | 1 |
| Drexel, H | 1 |
| von Eckardstein, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Developmental Impacts of MicroPLastics Exposure in Early Life[NCT06107933] | 40 participants (Anticipated) | Observational | 2023-10-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for trimethyloxamine and Metabolic Syndrome
| Article | Year |
|---|---|
Trimethylamine
Topics: Animals; Cholesterol; Gastrointestinal Microbiome; Gluconeogenesis; Humans; Lipogenesis; Liver; Meta | 2018 |
Unaccounted risk of cardiovascular disease: the role of the microbiome in lipid metabolism.
Topics: Animals; Atherosclerosis; Bile Acids and Salts; Carnitine; Choline; Energy Metabolism; Fatty Acids, | 2019 |
2 trials available for trimethyloxamine and Metabolic Syndrome
| Article | Year |
|---|---|
Impact of Hypoxia-Hyperoxia Exposures on Cardiometabolic Risk Factors and TMAO Levels in Patients with Metabolic Syndrome.
Topics: Cardiometabolic Risk Factors; Female; Humans; Hyperoxia; Hypoxia; Metabolic Syndrome; Methylamines; | 2023 |
Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study.
Topics: Adult; Austria; Biomarkers; Chromatography, Liquid; Female; Gastrointestinal Microbiome; Humans; Int | 2015 |
8 other studies available for trimethyloxamine and Metabolic Syndrome
| Article | Year |
|---|---|
Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome.
Topics: Adult; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Humans; Metabolic Syndrome; Methylamine | 2021 |
Serum Trimethylamine N-Oxide Levels Correlate with Metabolic Syndrome in Coronary Artery Disease Patients.
Topics: Biomarkers; C-Reactive Protein; Coronary Artery Disease; Glucose; Humans; Metabolic Syndrome; Methyl | 2022 |
Dietary supplementation of L-carnitine ameliorates metabolic syndrome independent of trimethylamine
Topics: Animals; Carnitine; Diet, High-Fat; Dietary Supplements; Gastrointestinal Microbiome; Humans; Metabo | 2022 |
Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction.
Topics: Animals; eIF-2 Kinase; Gastrointestinal Microbiome; HEK293 Cells; Hep G2 Cells; Humans; Indoles; Ins | 2019 |
Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort.
Topics: Aged; Amino Acids; Bacteria; Blood Glucose; Body Mass Index; Cohort Studies; Diabetes Mellitus, Type | 2017 |
Changes to trimethylamine-N-oxide and its precursors in nascent metabolic syndrome.
Topics: Adult; Aged; Biomarkers; Carnitine; Choline; Female; Humans; Inflammation; Male; Metabolic Syndrome; | 2018 |
Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome.
Topics: Adult; Biomarkers; Body Mass Index; Cross-Sectional Studies; Female; Habits; Humans; Life Style; Lin | 2018 |
Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Topics: Aged; Betaine; Biomarkers; Blood Glucose; Choline; Chromatography, Liquid; Coronary Angiography; Cor | 2015 |